Literature DB >> 19203437

The predictive value of measures of social cognition for community functioning in schizophrenia: implications for neuropsychological assessment.

G H M Pijnenborg1, F K Withaar, J J Evans, R J van den Bosch, M E Timmerman, W H Brouwer.   

Abstract

The objective of this study was to examine the unique contribution of social cognition to the prediction of community functioning and to explore the relevance of social cognition for clinical practice. Forty-six schizophrenia patients and 53 healthy controls were assessed with tests of social cognition [emotion perception and Theory of Mind (ToM)], general cognition, and, within the patient sample, psychiatric symptoms. Community functioning was rated by nurses or family members. Social cognition was a better predictor of community functioning than general cognition or psychiatric symptoms. When the contributions of emotion perception and ToM were examined separately, only ToM contributed significantly to the prediction of community functioning. Independent living skills were poor in patients with impaired social cognition. In controls, social cognition was not related to community functioning. ToM was the best predictor of community functioning in schizophrenia. However, to fully understand a patient's strengths and weaknesses, assessment of social cognition should always be combined with assessment of general cognition and psychiatric symptoms.

Entities:  

Mesh:

Year:  2009        PMID: 19203437     DOI: 10.1017/S1355617709090341

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  26 in total

Review 1.  Progress in defining optimal treatment outcome in schizophrenia.

Authors:  Gary Remington; George Foussias; Ofer Agid
Journal:  CNS Drugs       Date:  2010-01       Impact factor: 5.749

2.  Exploratory analysis of social cognition and neurocognition in individuals at clinical high risk for psychosis.

Authors:  Emma Yong; Mariapaola Barbato; David L Penn; Richard S E Keefe; Scott W Woods; Diana O Perkins; Jean Addington
Journal:  Psychiatry Res       Date:  2014-04-12       Impact factor: 3.222

3.  Subjective perceptions of cognitive deficits and their influences on quality of life among patients with schizophrenia.

Authors:  Alejandra Caqueo-Urízar; Laurent Boyer; Karine Baumstarck; Stephen E Gilman
Journal:  Qual Life Res       Date:  2015-06-03       Impact factor: 4.147

Review 4.  [Social psychiatry and neurobiology : A long overdue convergence exemplified by schizophrenia].

Authors:  W Kawohl; C Wyss; P Roser; M Brüne; W Rössler; G Juckel
Journal:  Nervenarzt       Date:  2017-05       Impact factor: 1.214

5.  Theory of mind in schizophrenia: exploring neural mechanisms of belief attribution.

Authors:  Junghee Lee; Javier Quintana; Poorang Nori; Michael F Green
Journal:  Soc Neurosci       Date:  2011       Impact factor: 2.083

6.  A meta-analysis of emotion perception and functional outcomes in schizophrenia.

Authors:  Farzin Irani; Sarah Seligman; Vidyulata Kamath; Christian Kohler; Ruben C Gur
Journal:  Schizophr Res       Date:  2012-02-15       Impact factor: 4.939

Review 7.  Neuropsychological Assessment: Past and Future.

Authors:  Kaitlin B Casaletto; Robert K Heaton
Journal:  J Int Neuropsychol Soc       Date:  2017-10       Impact factor: 2.892

Review 8.  What do we know about neuropsychological aspects of schizophrenia?

Authors:  Barton W Palmer; Sharron E Dawes; Robert K Heaton
Journal:  Neuropsychol Rev       Date:  2009-07-30       Impact factor: 7.444

9.  Premorbid cognitive deficits in young relatives of schizophrenia patients.

Authors:  Matcheri S Keshavan; Shreedhar Kulkarni; Tejas Bhojraj; Alan Francis; Vaibhav Diwadkar; Debra M Montrose; Larry J Seidman; John Sweeney
Journal:  Front Hum Neurosci       Date:  2010-03-09       Impact factor: 3.169

10.  Insight in schizophrenia: associations with empathy.

Authors:  G H M Pijnenborg; J M Spikman; B F Jeronimus; A Aleman
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-10-18       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.